Embryonic stem cell-derived extracellular vesicles enhance the therapeutic effect of mesenchymal stem cells

Embryonic stem cell-derived extracellular vesicles enhance the therapeutic effect of mesenchymal stem cells
复制标题

胚胎干细胞来源的细胞外囊泡增强间充质干细胞的治疗效果

DOI:
10.7150/thno.35305
复制
发表时间:
2019
期刊:
影响因子:
12.4
通讯作者:
Cui kaige
Cui kaige
中科院分区:
医学1区
文献类型:
--
作者:
Zhang Yan;Xu Jia;Liu Siying;Lim Meikuang;Zhao Shuang;Zhang Kaiyue;Wang Lingling;Ji Qian;Han Zhongchao;Kong Deling;Li Zongjin;Liu Na;Cui kaige

文献摘要

被引文献

相似文献

背景:胚胎干细胞(ES)在再生医学中具有巨大的细胞治疗潜力。然而,伦理和安全性问题限制了其临床应用。ES衍生的细胞外囊泡(ES-EV)已被报道抑制细胞衰老。骨髓间充质干细胞(Mesenchymal stem cells,MSCs)是目前临床上广泛应用的细胞疗法。在这项研究中,我们研究了ES-EV对衰老MSC的有益作用,以进一步增强其治疗效果。研究方法:在体外,我们通过衰老相关β-gal(SA-β-gal)染色、免疫组化染色和DNA损伤灶分析来探讨ES-EV对衰老MSCs的复壮作用。通过小鼠皮肤创伤模型评价ES-EV预处理的衰老MSC的治疗效果。结果如下:我们发现ES-EV在体外显著地使衰老的MSC年轻化,并且在小鼠皮肤创伤模型中改善MSC的治疗效果。此外,我们还发现IGF 1/PI 3 K/AKT通路介导了ES-EV对MSCs的抗衰老作用。结论:结果表明,ES细胞来源的细胞外囊泡具有抗衰老的特性,能显著地使衰老的MSCs恢复活力,增强MSCs的治疗效果。这种策略可能成为MSCs临床应用的一种新的治疗策略。
Background: Embryonic stem cells (ES) have a great potential for cell-based therapies in a regenerative medicine. However, the ethical and safety issues limit its clinical application. ES-derived extracellular vesicles (ES-EVs) have been reported suppress cellular senescence. Mesenchymal stem cells (MSCs) are widely used for clinical cell therapy. In this study, we investigated the beneficial effects of ES-EVs on aging MSCs to further enhancing their therapeutic effects. Methods: In vitro, we explored the rejuvenating effects of ES-EVs on senescent MSCs by senescence-associated β-gal (SA-β-gal) staining, immunostaining, and DNA damage foci analysis. The therapeutic effect of senescent MSC pre-treated with ES-EVs was also evaluated by using mouse cutaneous wound model. Results: We found that ES-EVs significantly rejuvenated the senescent MSCs in vitro and improve the therapeutic effects of MSCs in a mouse cutaneous wound model. In addition, we also identified that the IGF1/PI3K/AKT pathway mediated the antisenescence effects of ES-EVs on MSCs. Conclusions: Our results suggested that ES cells derived-extracellular vesicles possess the antisenescence properties, which significantly rejuvenate the senescent MSCs and enhance the therapeutic effects of MSCs. This strategy might emerge as a novel therapeutic strategy for MSCs clinical application.